Phibro Animal Health (PAHC) Capital Expenditures (2013 - 2026)
Phibro Animal Health (PAHC) posted quarterly Capital Expenditures of -$25.6 million for Q1 2026, down 431.11% year-over-year from $7.7 million in Q1 2025, and down 203.43% quarter-over-quarter from $24.8 million in Q4 2025.
Phibro Animal Health (PAHC) Capital Expenditures (2013 - 2026) Analysis & Trends
Phibro Animal Health's Capital Expenditures history runs 14 years deep, the most recent figure standing at -$25.6 million for Q1 2026.
- In Q1 2026, Capital Expenditures fell 431.11% year-over-year to -$25.6 million; the TTM figure through Mar 2026 stood at $12.4 million (down 67.57% YoY), while the FY2025 annual figure was $38.3 million, down 7.14% from the prior year.
- Capital Expenditures for Q1 2026 stood at -$25.6 million, down from $24.8 million in the prior quarter.
- The five-year high for Capital Expenditures was $41.9 million in Q1 2023, with the low at -$25.6 million in Q1 2026.
- The 5-year median for Capital Expenditures is $9.7 million (2024), against an average of $7.0 million.
- The sharpest annual moves came in 2024 and 2026: Capital Expenditures jumped 4917.28% in 2024, then plunged 431.11% in 2026.
- Phibro Animal Health's Capital Expenditures stood at -$24.2 million in 2022, then soared by 175.35% to $18.2 million in 2023, then slumped by 57.13% to $7.8 million in 2024, then jumped by 217.03% to $24.8 million in 2025, then tumbled by 203.43% to -$25.6 million in 2026.
- Business Quant data shows PAHC's Capital Expenditures at -$25.6 million in Q1 2026, $24.8 million in Q4 2025, and $105000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 104.00 Mn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 117.00 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -337.60 Mn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 108.00 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 52.80 Mn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 7.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 33.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Phibro Animal Health | 1.42 Bn | 1.35 Bn | 125.68 Mn | 15.32 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -25.65 Mn |
| Mar 31, 2026 | -25.65 Mn |
| Dec 31, 2025 | 24.80 Mn |
| Dec 31, 2025 | 24.80 Mn |
| Sep 30, 2025 | 105,000.00 |
| Sep 30, 2025 | 105,000.00 |
| Jun 30, 2025 | 13.14 Mn |
| Jun 30, 2025 | 13.14 Mn |
| Mar 31, 2025 | 7.75 Mn |
| Mar 31, 2025 | 7.75 Mn |
| Dec 31, 2024 | 7.82 Mn |
| Dec 31, 2024 | 7.82 Mn |
| Sep 30, 2024 | 9.58 Mn |
| Sep 30, 2024 | 9.58 Mn |
| Jun 30, 2024 | 13.07 Mn |
| Jun 30, 2024 | 13.07 Mn |
| Mar 31, 2024 | 9.73 Mn |
| Mar 31, 2024 | 9.73 Mn |
| Dec 31, 2023 | 18.24 Mn |
| Dec 31, 2023 | 18.24 Mn |